TMCnet News
How Behavioral Profiles Can Reduce Drop-Off and Sustain Weight Loss, Upcoming Webinar Hosted by XtalksIn this free webinar, learn how behavioral profiles can help identify adherence risk and support more personalized weight-management programs. The featured speakers will discuss how psychological factors, treatment beliefs and objective biometric data can help explain why some patients stay on therapy and others discontinue. Attendees will also explore how combining behavioral, biometric and social data can support earlier outreach and more sustained functional weight loss. TORONTO, Oct. 14, 2026 /PRNewswire/ -- Weight-loss medications work only while patients keep taking them. The real goal is staying on medication long enough to achieve meaningful, functional weight loss and sustain it. This webinar explores why that's harder than it sounds: not for the clinical reasons often expected, but rather because of the beliefs and psychology, including the significance of volitional medication use in obesity, that predict who stays engaged and who drops off before seeing the long-term benefits.
For pharma professionals supporting an obesity portfolio, that gap is an important challenge to address. Clinical trials show sustained weight reduction of 15–22% over 72 weeks, but real-world discontinuation can be up to 67% within 12 months. Side effects, cost and access explain only part of that drop-off. Most support programs have no validated way to identify behavioral risk before it impacts success. Psychological factors, such as confidence, doubt and treatment identity, are increasingly recognized as independent predictors of discontinuation. Underlying motivations and beliefs about treatment, whether rooted in appearance, day-to-day function or long-term health risk, differ from patient to patient. Left unaddressed, these differences can determine whether someone stays on treatment and reaches a functional, lasting outcome. Digital health technology can help keep people engaged and on track. The featured speakers will discuss findings from a novel study of 1,056 US adults using a GLP-1/GIP medication for weight management, evaluated usng the SPUR behavioral framework alongside validated belief and mental-health measures. They'll introduce Kaitality™, Clinical ink's general wellness app, and show how connecting biometrics (weight, body composition and activity), sociometrics (social context and daily environment) and psychometrics (validated psychological drivers of adherence) can generate real-world evidence and support progress toward sustained functional quality weight loss goals. Register for this webinar to learn how a behavioral profile can help identify adherence risk, personalize patient support and support sustained functional weight loss. Join experts from Clinical ink, Christian Djurhuus, MD, PhD, EVP Disease Management, Chief Scientific Officer; Nicholas Alp, MD, PhD, FACC Chief Medical Officer; and Bob DiLuzio (Moderator), Senior Vice President, Disease Management, for the live webinar on Thursday, October 29, 2026, at 11am EDT (4pm CET / EU-Central). For more information, or to register for this event, visit How Behavioral Profiles Can Reduce Drop-Off and Sustain Weight Loss. ABOUT XTALKS Xtalks – The Life Science Community™ empowers professionals across pharma, biotech, medtech, healthcare and research with the trusted knowledge and collaborative insights that move the industry forward. Powered by Honeycomb Worldwide Inc., Xtalks delivers news, feature articles, webinars, podcasts, videos, expert interviews, curated job opportunities and more designed to support informed decision-making in a fast-evolving sector. Every year, thousands of professionals rely on Xtalks for timely intelligence, peer perspectives and industry thought leadership. Join our life science community to stay informed, connected and ready for what's next. To learn more about Xtalks, visit www.xtalks.com Contact:
SOURCE Xtalks 
|
View original content to download multimedia: